Skip to main content
Erschienen in: Journal of General Internal Medicine 1/2020

12.09.2019

Impact of a Patient-Centered Behavioral Economics Intervention on Hypertension Control in a Highly Disadvantaged Population: a Randomized Trial

verfasst von: Martin F. Shapiro, MD, CM, PhD, Suzanne B. Shu, PhD, Noah J. Goldstein, PhD, Ronald G. Victor, MD, Craig R. Fox, PhD, Chi-Hong Tseng, PhD, Sitaram Vangala, MA, Braden K. Mogler, MD, Stewart B. Reed, MD, Estivali Villa, BA, José J. Escarce, MD, PhD

Erschienen in: Journal of General Internal Medicine | Ausgabe 1/2020

Einloggen, um Zugang zu erhalten

Abstract

Background

Uncontrolled hypertension contributes to disparities in cardiovascular outcomes. Patient intervention strategies informed by behavioral economics and social psychology could improve blood pressure (BP) control in disadvantaged minority populations.

Objective

To assess the impact on BP control of an intervention combining short-term financial incentives with promotion of intrinsic motivation among highly disadvantaged patients.

Design

Randomized controlled trial.

Participants

Two hundred seven adults (98% African American or Latino) aged 18 or older with uncontrolled hypertension attending Federally Qualified Health Centers.

Intervention

Six-month intervention, combining financial incentives for measuring home BP, recording medication use, BP improvement, and achieving target BP values with counseling linking hypertension control efforts to participants’ personal reasons to stay healthy.

Main Measures

Primary outcomes: percentage achieving systolic BP (SBP) < 140 mmHg, percentage achieving diastolic BP (DBP) < 90 mmHg, and changes in SBP and DBP, all after 6 months. Priority secondary outcomes were SBP < 140 mmHg, DBP < 90 mmHg, and BP change at 12 months, 6 months after the intervention ended.

Key Results

After 6 months, rates of achieving target BP values for intervention and control subjects respectively was 57.1% vs. 40.2% for SBP < 140 mmHg (adjusted odds ratio (AOR) 2.53 (1.13–5.70)), 79.8% vs 70.1% for DBP < 90 mmHg (AOR 2.50 (0.84–7.44)), and 53.6% vs 40.2% for achieving both targets (AOR 2.04 (0.92–4.52)). However, at 12 months, the groups did not differ significantly in these 3 measures: 39.5% vs 35.0% for SBP (AOR 1.20 (0.51–2.83)), 68.4% vs 75.0% for DBP (AOR 0.70 (0.24–2.09)), and 35.5% vs 33.8% for both (AOR 1.03 (0.44–2.42)). Change in absolute SBP and DBP did not differ significantly between the groups at 6 or 12 months. Exploratory post hoc analysis revealed intervention benefit only occurred among individuals whose providers intensified their regimens, but not among those with intensification but no intervention.

Conclusions

The intervention achieved short-term improvement in SBP control in a highly disadvantaged population. Despite attempts to enhance intrinsic motivation, the effect was not sustained after incentives were withdrawn. Future research should evaluate combined patient/provider strategies to enhance such interventions and sustain their benefit.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Victor RG, Leonard D, Hess P, et al. Factors Associaed with Hypertension Awareness, Treatment, and Control in Dallas County, Texas, Arch Intern Med. 2008;168(12):1285–93.PubMed Victor RG, Leonard D, Hess P, et al. Factors Associaed with Hypertension Awareness, Treatment, and Control in Dallas County, Texas, Arch Intern Med. 2008;168(12):1285–93.PubMed
2.
Zurück zum Zitat Wilber JA, Barrow JG. Hypertension--a community problem. Am J Med. 1972;52(5):653–63.PubMed Wilber JA, Barrow JG. Hypertension--a community problem. Am J Med. 1972;52(5):653–63.PubMed
3.
Zurück zum Zitat Stamler J, Stamler R, Riedlinger WF, Algera G, Roberts RH. Hypertension screening of 1 million Americans. Community Hypertension Evaluation Clinic (CHEC) program, 1973 through 1975. JAMA. 1976;235(21):2299–306.PubMed Stamler J, Stamler R, Riedlinger WF, Algera G, Roberts RH. Hypertension screening of 1 million Americans. Community Hypertension Evaluation Clinic (CHEC) program, 1973 through 1975. JAMA. 1976;235(21):2299–306.PubMed
4.
Zurück zum Zitat Blood pressure studies in 14 communities. A two-stage screen for hypertension. JAMA. 1977;237(22):2385–91. Blood pressure studies in 14 communities. A two-stage screen for hypertension. JAMA. 1977;237(22):2385–91.
5.
Zurück zum Zitat Radice M, Alberti D, Alli C, Avanzini F, Di Tullio M, Mariotti G, et al. Long-term efficacy of screening for hypertension in a community. J Hypertens. 1985;3(3):255–9.PubMed Radice M, Alberti D, Alli C, Avanzini F, Di Tullio M, Mariotti G, et al. Long-term efficacy of screening for hypertension in a community. J Hypertens. 1985;3(3):255–9.PubMed
6.
Zurück zum Zitat Cooke CJ, Meyers A. The Role of Community Volunteers in Health Interventions: a Hypertension Screening and Follow-Up Program. Am J Public Health. 1983;73(2):193–4.PubMedPubMedCentral Cooke CJ, Meyers A. The Role of Community Volunteers in Health Interventions: a Hypertension Screening and Follow-Up Program. Am J Public Health. 1983;73(2):193–4.PubMedPubMedCentral
7.
Zurück zum Zitat Ambrosio GB, Strasser T, Dowd JE, Tuomilehto J, Nissinen A, Froment A, et al. Effects of Interventions on Community Awareness and Treatment of Hypertension: Results of a WHO Study. Bull World Health Organ. 1988;66(1):107–13.PubMedPubMedCentral Ambrosio GB, Strasser T, Dowd JE, Tuomilehto J, Nissinen A, Froment A, et al. Effects of Interventions on Community Awareness and Treatment of Hypertension: Results of a WHO Study. Bull World Health Organ. 1988;66(1):107–13.PubMedPubMedCentral
8.
Zurück zum Zitat Baird MG, Bentley-Taylor MM, Carruthers SG, Dawson KG, Laplante LE, Larochelle P, et al. A Study of Efficacy, Tolerance and Compliance of Once-Daily Versus Twice-Daily Metoprolol (Betaloc) in Hypertension. Betaloc Compliance Canadian Cooperative Study Group. Clin Invest Med. 1984;7(2):95–102.PubMed Baird MG, Bentley-Taylor MM, Carruthers SG, Dawson KG, Laplante LE, Larochelle P, et al. A Study of Efficacy, Tolerance and Compliance of Once-Daily Versus Twice-Daily Metoprolol (Betaloc) in Hypertension. Betaloc Compliance Canadian Cooperative Study Group. Clin Invest Med. 1984;7(2):95–102.PubMed
9.
Zurück zum Zitat Becker LA, Glanz K, Sobel E, Mossey J, Zinn SL, Knott KA. A Randomized Trial of Special Packaging of Antihypertensive Medications. J Fam Pract. 1986;22(4):357–61.PubMed Becker LA, Glanz K, Sobel E, Mossey J, Zinn SL, Knott KA. A Randomized Trial of Special Packaging of Antihypertensive Medications. J Fam Pract. 1986;22(4):357–61.PubMed
10.
Zurück zum Zitat Brown BG, Bardsley J, Poulin D, Hillger LA, Dowdy A, Maher VM, et al. Moderate Dose, Three-Drug Therapy with Niacin, lovastatin, and Colestipol to Reduce Low-Density Lipoprotein Cholesterol <100 mg/dl in Patients with Hyperlipidemia and Coronary Artery Disease. Am J Cardiol. 1997;80(2):111–5.PubMed Brown BG, Bardsley J, Poulin D, Hillger LA, Dowdy A, Maher VM, et al. Moderate Dose, Three-Drug Therapy with Niacin, lovastatin, and Colestipol to Reduce Low-Density Lipoprotein Cholesterol <100 mg/dl in Patients with Hyperlipidemia and Coronary Artery Disease. Am J Cardiol. 1997;80(2):111–5.PubMed
11.
Zurück zum Zitat Friedman RH, Kazis LE, Jette A, Smith MB, Stollerman J, Torgerson J, et al. A Telecommunications System for Monitoring and Counseling Patients with Hypertension. Impact on Medication Adherence and Blood Pressure Control. Am J Hypertens. 1996;9(4 Pt 1):285–92.PubMed Friedman RH, Kazis LE, Jette A, Smith MB, Stollerman J, Torgerson J, et al. A Telecommunications System for Monitoring and Counseling Patients with Hypertension. Impact on Medication Adherence and Blood Pressure Control. Am J Hypertens. 1996;9(4 Pt 1):285–92.PubMed
12.
Zurück zum Zitat Girvin B, McDermott BJ, Johnston GD. A Comparison of Enalapril 20 mg Once Daily versus 10 mg Twice Daily in Terms of Blood Pressure Lowering and Patient Compliance. J Hypertens. 1999;17(11):1627–31.PubMed Girvin B, McDermott BJ, Johnston GD. A Comparison of Enalapril 20 mg Once Daily versus 10 mg Twice Daily in Terms of Blood Pressure Lowering and Patient Compliance. J Hypertens. 1999;17(11):1627–31.PubMed
13.
Zurück zum Zitat Haynes RB, Sackett DL, Gibson ES, Taylor DW, Hackett BC, Roberts RS, et al. Improvement of Medication Compliance in Uncontrolled Hypertension. Lancet. 1976;1(7972):1265–8.PubMed Haynes RB, Sackett DL, Gibson ES, Taylor DW, Hackett BC, Roberts RS, et al. Improvement of Medication Compliance in Uncontrolled Hypertension. Lancet. 1976;1(7972):1265–8.PubMed
14.
Zurück zum Zitat Johnson AL, Taylor DW, Sackett DL, Dunnett CW, Shimizu AG. Self-recording of Blood Pressure in the Management of Hypertension. Can Med Assoc J. 1978;119(9):1034–9.PubMedPubMedCentral Johnson AL, Taylor DW, Sackett DL, Dunnett CW, Shimizu AG. Self-recording of Blood Pressure in the Management of Hypertension. Can Med Assoc J. 1978;119(9):1034–9.PubMedPubMedCentral
15.
Zurück zum Zitat Mosca L, Linfante AH, Benjamin EJ, Berra K, Hayes SN, Walsh BW, et al. National Study of Physician Awareness and Adherence to Cardiovascular Disease Prevention Guidelines. Circulation. 2005;111(4):499–510.PubMed Mosca L, Linfante AH, Benjamin EJ, Berra K, Hayes SN, Walsh BW, et al. National Study of Physician Awareness and Adherence to Cardiovascular Disease Prevention Guidelines. Circulation. 2005;111(4):499–510.PubMed
16.
Zurück zum Zitat Hagemeister J, Schneider CA, Barabas S, Schadt R, Wassmer G, Mager G, et al. Hypertension Guidelines and Their Limitations--the Impact of Physicians' Compliance as Evaluated by Guideline Awareness. J Hypertens. 2001;19(11):2079–86.PubMed Hagemeister J, Schneider CA, Barabas S, Schadt R, Wassmer G, Mager G, et al. Hypertension Guidelines and Their Limitations--the Impact of Physicians' Compliance as Evaluated by Guideline Awareness. J Hypertens. 2001;19(11):2079–86.PubMed
17.
Zurück zum Zitat Millett C, Gray J, Bottle A, Majeed A. Ethnic Disparities in Blood Pressure Management in Patients with Hypertension after the Introduction of Pay for Performance. Ann Fam Med. 2008;6(6):490–6.PubMedPubMedCentral Millett C, Gray J, Bottle A, Majeed A. Ethnic Disparities in Blood Pressure Management in Patients with Hypertension after the Introduction of Pay for Performance. Ann Fam Med. 2008;6(6):490–6.PubMedPubMedCentral
18.
Zurück zum Zitat Tsuyuki RT, Houle SKD, Charrois TL, Kolber MR, Rosenthal MM, Lewanczuk R, et al. A Randomized Trial of the Effect of Pharmacist Prescribing on Improving Blood Pressure in the Community: The Alberta Clinical Trial in Optimizing Hypertension (RxACTION). Circulation. 2015;132(2):93–100.PubMed Tsuyuki RT, Houle SKD, Charrois TL, Kolber MR, Rosenthal MM, Lewanczuk R, et al. A Randomized Trial of the Effect of Pharmacist Prescribing on Improving Blood Pressure in the Community: The Alberta Clinical Trial in Optimizing Hypertension (RxACTION). Circulation. 2015;132(2):93–100.PubMed
19.
Zurück zum Zitat Victor RG. Expanding Pharmacists’ Role in the Era of Health Care Reform. Am J Health Syst Pharm. 2012;69(22):1959.PubMed Victor RG. Expanding Pharmacists’ Role in the Era of Health Care Reform. Am J Health Syst Pharm. 2012;69(22):1959.PubMed
20.
Zurück zum Zitat Jaffe MG, Lee GA, Young JD, Sidney S, Go AS. Improved Blood Pressure Control Associated with a Large-Scale Hypertension Program. JAMA. 2013;310(7):699–705.PubMedPubMedCentral Jaffe MG, Lee GA, Young JD, Sidney S, Go AS. Improved Blood Pressure Control Associated with a Large-Scale Hypertension Program. JAMA. 2013;310(7):699–705.PubMedPubMedCentral
21.
Zurück zum Zitat Poulter NR, Prabhakaran D, Caulfield M. Hypertension. Lancet. 2015;386(9995):801–12.PubMed Poulter NR, Prabhakaran D, Caulfield M. Hypertension. Lancet. 2015;386(9995):801–12.PubMed
22.
Zurück zum Zitat Mullainthan S, Shafir E. Scarcity: Why Having so Little Means so Much. New York, Times Books, Henry Holt and Company, 2013. Mullainthan S, Shafir E. Scarcity: Why Having so Little Means so Much. New York, Times Books, Henry Holt and Company, 2013.
23.
Zurück zum Zitat Houle SK, McAlister FA, Jackevicius CA, Chuck AW, Tsuyuki RT. Does Performance-Based Remuneration for Individual Health Care Practitioners Affect Patient Care?: A Systematic Review. Ann Intern Med. 2012;157(12):889–99.PubMed Houle SK, McAlister FA, Jackevicius CA, Chuck AW, Tsuyuki RT. Does Performance-Based Remuneration for Individual Health Care Practitioners Affect Patient Care?: A Systematic Review. Ann Intern Med. 2012;157(12):889–99.PubMed
25.
Zurück zum Zitat Ryan RM, Deci EL. Self-Determination Theory and the Facilitation of Intrinsic Motivation, Social Development, and Well-Being. Am Psychol. 2000;55(1):68–78.PubMed Ryan RM, Deci EL. Self-Determination Theory and the Facilitation of Intrinsic Motivation, Social Development, and Well-Being. Am Psychol. 2000;55(1):68–78.PubMed
26.
Zurück zum Zitat Cialdini R. B., Eisenberg N. E., Green B. L., Rhoads K., Bator R. Undermining the Undermining Effect of Reward on Sustained Interest. J Appl Soc Psychol. 1998;28(3):249–63. Cialdini R. B., Eisenberg N. E., Green B. L., Rhoads K., Bator R. Undermining the Undermining Effect of Reward on Sustained Interest. J Appl Soc Psychol. 1998;28(3):249–63.
27.
Zurück zum Zitat Victor RG, Haley RW, Willett DL, Peshock RM, Vaeth PC, Leonard D, et al. The Dallas Heart Study: a Population-Based Probability Sample for the Multidisciplinary Study of Ethnic Differences in Cardiovascular Health. Am J Cardiol. 2004;93(12):1473–80.PubMed Victor RG, Haley RW, Willett DL, Peshock RM, Vaeth PC, Leonard D, et al. The Dallas Heart Study: a Population-Based Probability Sample for the Multidisciplinary Study of Ethnic Differences in Cardiovascular Health. Am J Cardiol. 2004;93(12):1473–80.PubMed
28.
Zurück zum Zitat Victor RG, Ravenell JE, Freeman A, et al. Effectiveness of a Barber-Based Intervention for Improving Hypertension Control in Black Men: The barber-1 study: a Cluster Randomized Trial. Arch Intern Med. 2011;171(4):342–50.PubMed Victor RG, Ravenell JE, Freeman A, et al. Effectiveness of a Barber-Based Intervention for Improving Hypertension Control in Black Men: The barber-1 study: a Cluster Randomized Trial. Arch Intern Med. 2011;171(4):342–50.PubMed
29.
Zurück zum Zitat Cote I, Gregoire JP, Moisan J, Chabot I. Quality of Life in Hypertension: the SF-12 Compared to the SF-36. Can J Clin Pharmacol = Journal Canadien de Pharmacologie Clinique. 2004;11(2):e232–8.PubMed Cote I, Gregoire JP, Moisan J, Chabot I. Quality of Life in Hypertension: the SF-12 Compared to the SF-36. Can J Clin Pharmacol = Journal Canadien de Pharmacologie Clinique. 2004;11(2):e232–8.PubMed
30.
Zurück zum Zitat Fernandez S, Chaplin W, Schoenthaler AM, Ogedegbe G. Revision and Validation of the Medication Adherence Self-Efficacy Scale (MASES) in Hypertensive African Americans. J Behav Med. 2008;31(6):453–62.PubMedPubMedCentral Fernandez S, Chaplin W, Schoenthaler AM, Ogedegbe G. Revision and Validation of the Medication Adherence Self-Efficacy Scale (MASES) in Hypertensive African Americans. J Behav Med. 2008;31(6):453–62.PubMedPubMedCentral
31.
Zurück zum Zitat Warren-Findlow J, Seymour RB, Brunner Huber LR. The Association Between Self-Efficacy and Hypertension Self-Care Activities Among African American Adults. J Commun Health. 2012;37(1):15–24. Warren-Findlow J, Seymour RB, Brunner Huber LR. The Association Between Self-Efficacy and Hypertension Self-Care Activities Among African American Adults. J Commun Health. 2012;37(1):15–24.
32.
Zurück zum Zitat Hibbard JH, Stockard J, Mahoney ER, Tusler M. Development of the Patient Activation Measure (PAM): Conceptualizing and Measuring Activation in Patients and Consumers. Health Serv Res. 2004;39(4 Pt 1):1005–26.PubMedPubMedCentral Hibbard JH, Stockard J, Mahoney ER, Tusler M. Development of the Patient Activation Measure (PAM): Conceptualizing and Measuring Activation in Patients and Consumers. Health Serv Res. 2004;39(4 Pt 1):1005–26.PubMedPubMedCentral
33.
Zurück zum Zitat Crooks VC, Lubben J, Petitti DB, Little D, Chiu V. Social Network, Cognitive Function, and Dementia Incidence Among Elderly Women. Am J Public Health. 2008;98(7):1221–7.PubMedPubMedCentral Crooks VC, Lubben J, Petitti DB, Little D, Chiu V. Social Network, Cognitive Function, and Dementia Incidence Among Elderly Women. Am J Public Health. 2008;98(7):1221–7.PubMedPubMedCentral
34.
Zurück zum Zitat Moser A, Stuck AE, Silliman RA, Ganz PA, Clough-Gorr KM. The Eight-Item Modified Medical Outcomes Study Social Support Survey: Psychometric Evaluation Showed Excellent Performance. J Clin Epidemiol. 2012;65(10):1107–16.PubMedPubMedCentral Moser A, Stuck AE, Silliman RA, Ganz PA, Clough-Gorr KM. The Eight-Item Modified Medical Outcomes Study Social Support Survey: Psychometric Evaluation Showed Excellent Performance. J Clin Epidemiol. 2012;65(10):1107–16.PubMedPubMedCentral
35.
Zurück zum Zitat Cunningham WE, Andersen RM, Katz MH, Stein MD, Turner BJ, Crystal S, et al. The Impact of Competing Subsistence Needs and Barriers on Access to Medical Care for Persons with Human Immunodeficiency Virus Receiving Care in the United States. Med Care. 1999;37(12):1270–81.PubMed Cunningham WE, Andersen RM, Katz MH, Stein MD, Turner BJ, Crystal S, et al. The Impact of Competing Subsistence Needs and Barriers on Access to Medical Care for Persons with Human Immunodeficiency Virus Receiving Care in the United States. Med Care. 1999;37(12):1270–81.PubMed
36.
Zurück zum Zitat The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Bethesda, Maryland, United States Department of Health Services, National Institutes of Health, National Heart, Lung, and Blood Institute Publication No. 04–5230, 2004. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Bethesda, Maryland, United States Department of Health Services, National Institutes of Health, National Heart, Lung, and Blood Institute Publication No. 04–5230, 2004.
37.
Zurück zum Zitat Tversky A, Kahneman D. Advances in Prospect Theory: Cumulative representation of Uncertainty. J Risk Uncertain. 1992;5(4):297–323. Tversky A, Kahneman D. Advances in Prospect Theory: Cumulative representation of Uncertainty. J Risk Uncertain. 1992;5(4):297–323.
38.
Zurück zum Zitat American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. 2017 Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. J Am Coll Cardiol. 2017, 23976; https://doi.org/10.1016/j.jacc.2017.07.74. Correction J Am Coll Cardiol 2018;71:e127–248.5 American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. 2017 Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. J Am Coll Cardiol. 2017, 23976; https://​doi.​org/​10.​1016/​j.​jacc.​2017.​07.​74. Correction J Am Coll Cardiol 2018;71:e127–248.5
39.
Zurück zum Zitat Worldwide Trends in Blood Pressure from 1975 to 2015: a Pooled Analysis of 1479 Population-Based Measurement Studies with 19·1 Million Participants. Lancet. 2017;389(10064):37–55. Worldwide Trends in Blood Pressure from 1975 to 2015: a Pooled Analysis of 1479 Population-Based Measurement Studies with 19·1 Million Participants. Lancet. 2017;389(10064):37–55.
40.
Zurück zum Zitat VanEpps EM, Troxel AB, Villamil E, Saulsgiver KA, Zhu J, Chin J-Y, et al. Financial Incentives for Chronic Disease Management: Resultd and Limitations of 2 Randomized Clinical Trials With New York Medicaid Patioents. Am J Health Promot 2018;32(7):1537–43.PubMed VanEpps EM, Troxel AB, Villamil E, Saulsgiver KA, Zhu J, Chin J-Y, et al. Financial Incentives for Chronic Disease Management: Resultd and Limitations of 2 Randomized Clinical Trials With New York Medicaid Patioents. Am J Health Promot 2018;32(7):1537–43.PubMed
41.
Zurück zum Zitat Mani A, Mullainathan S, Shafir E, Zhao J. Poverty Impedes Cognitive Function. Science 2013;341(6149):976–80.PubMed Mani A, Mullainathan S, Shafir E, Zhao J. Poverty Impedes Cognitive Function. Science 2013;341(6149):976–80.PubMed
42.
Zurück zum Zitat Pocock SJ, Bakris G, Bhatt DL, Brar S, Fahy M, Bersh BJ. Regression to the mean in SYMPLICITY HTN-3. J Am Coll Cardiol. 2016;68(18):2016–2025.PubMed Pocock SJ, Bakris G, Bhatt DL, Brar S, Fahy M, Bersh BJ. Regression to the mean in SYMPLICITY HTN-3. J Am Coll Cardiol. 2016;68(18):2016–2025.PubMed
43.
Zurück zum Zitat Wilhelm M, Winkler A, Rief W, Doerning BK. Effect of placebo groups on blood pressure in hypertension: a meta-analysis of beta-blocker trials. J Am Soc Hypertension 2016;10(12):917–929. Wilhelm M, Winkler A, Rief W, Doerning BK. Effect of placebo groups on blood pressure in hypertension: a meta-analysis of beta-blocker trials. J Am Soc Hypertension 2016;10(12):917–929.
44.
Zurück zum Zitat Souza WK, Jardim PC, Brito LP, Araújo FA, Sousa AL. Self measurement of Blood Pressure for Control of Blood Pressure Levels and Adherence to Treatment. Arq Bras Cardiol. 2012;98(2):167–74.PubMed Souza WK, Jardim PC, Brito LP, Araújo FA, Sousa AL. Self measurement of Blood Pressure for Control of Blood Pressure Levels and Adherence to Treatment. Arq Bras Cardiol. 2012;98(2):167–74.PubMed
45.
Zurück zum Zitat Cahill K, Hartmann-Boyce J, Perera R. Incentives for smoking cessation. Cochrane Database Syst Rev. 2015;(5):CD004307. Cahill K, Hartmann-Boyce J, Perera R. Incentives for smoking cessation. Cochrane Database Syst Rev. 2015;(5):CD004307.
46.
Zurück zum Zitat Mantzari E, Vogt F, Shemilt I, Wei Y, Higgins JPT, Marteau TM. Personal financial incentives for changing habitual health-related behaviors: A systematic review and meta-analysis. Prev Med. 2015;75:75–85.PubMedPubMedCentral Mantzari E, Vogt F, Shemilt I, Wei Y, Higgins JPT, Marteau TM. Personal financial incentives for changing habitual health-related behaviors: A systematic review and meta-analysis. Prev Med. 2015;75:75–85.PubMedPubMedCentral
48.
Zurück zum Zitat Volpp KG, Troxel AB, Mehta SJ et al. Effect of electronic reminders, financial incentives, and social support on outcomes after myocardial infarction. JAMA Intern Med. 2017;177(8):1093–1101PubMedPubMedCentral Volpp KG, Troxel AB, Mehta SJ et al. Effect of electronic reminders, financial incentives, and social support on outcomes after myocardial infarction. JAMA Intern Med. 2017;177(8):1093–1101PubMedPubMedCentral
50.
Zurück zum Zitat Asch DA, Troxel AB, Stewart WF et al. Effect of financial incentives to physicians, patients, or both on lipid levels. A randomized trial. JAMA. 2015;314(18):1926–35PubMedPubMedCentral Asch DA, Troxel AB, Stewart WF et al. Effect of financial incentives to physicians, patients, or both on lipid levels. A randomized trial. JAMA. 2015;314(18):1926–35PubMedPubMedCentral
51.
Zurück zum Zitat Sen AP, Sewell TB, Riley EB et al. Financial incentives for home-based health monitoring. A randomized trial. J Gen Intern Med. 2014; 29(5):770–7PubMedPubMedCentral Sen AP, Sewell TB, Riley EB et al. Financial incentives for home-based health monitoring. A randomized trial. J Gen Intern Med. 2014; 29(5):770–7PubMedPubMedCentral
53.
Zurück zum Zitat Promberger M, Marteau TM. When do financial incentives reduce intrinsic motivation? Comparing behaviors in psychological and economic literature. Health Psychol. 2013;32(9):950–7PubMedPubMedCentral Promberger M, Marteau TM. When do financial incentives reduce intrinsic motivation? Comparing behaviors in psychological and economic literature. Health Psychol. 2013;32(9):950–7PubMedPubMedCentral
54.
Zurück zum Zitat Murayama K, Matsumoto M, Izuma K, Matdsumoto K. Neural basis of the undermining effect of monetary reward on intrinsic motivation. PNAS. 2010; 107(49):20911–6PubMed Murayama K, Matsumoto M, Izuma K, Matdsumoto K. Neural basis of the undermining effect of monetary reward on intrinsic motivation. PNAS. 2010; 107(49):20911–6PubMed
55.
Zurück zum Zitat Shah N. Introduction. In Cohen IG, Lynch HF, Robertson CT (eds). Nudging Health: Health Law and Behavioral Economics. Baltimore, Johns Hopkins University Press 2016:187–9. Shah N. Introduction. In Cohen IG, Lynch HF, Robertson CT (eds). Nudging Health: Health Law and Behavioral Economics. Baltimore, Johns Hopkins University Press 2016:187–9.
56.
Zurück zum Zitat Underhill K. Extrinsic incentives, intrinsic motivation, and motivational crowding out in health law and policy. In Cohen IG, Lynch HF, Robertson CT (eds). Nudging Health: Health Law and Behavioral Economics. Baltimore, Johns Hopkins University Press 2016:190–201. Underhill K. Extrinsic incentives, intrinsic motivation, and motivational crowding out in health law and policy. In Cohen IG, Lynch HF, Robertson CT (eds). Nudging Health: Health Law and Behavioral Economics. Baltimore, Johns Hopkins University Press 2016:190–201.
57.
Zurück zum Zitat Sen AP, Hffman D, Loewenstein G, Asch DA, Kullgren JT, Volpp KG. Do financial incentives reduce intrinsic motivation for weight loss? Underhill K. Extrinsic incentives, intrinsic motivation, and motivational crowding out in health law and policy. In Cohen IG, Lynch HF, Robertson CT (eds). Nudging Health: Health Law and Behavioral Economics. Baltimore, Johns Hopkins University Press 2016:202–16. Sen AP, Hffman D, Loewenstein G, Asch DA, Kullgren JT, Volpp KG. Do financial incentives reduce intrinsic motivation for weight loss? Underhill K. Extrinsic incentives, intrinsic motivation, and motivational crowding out in health law and policy. In Cohen IG, Lynch HF, Robertson CT (eds). Nudging Health: Health Law and Behavioral Economics. Baltimore, Johns Hopkins University Press 2016:202–16.
58.
Zurück zum Zitat Drawz PE, Pajewski NM, Bates JT, et al. Effect of Intensive Versus Standard Clinic-Based Hypertension Management on Ambulatory Blood Pressure: Results From the SPRINT Ambulatory Blood Pressure Study. Hypertension. 2017;69(1):42–50.PubMed Drawz PE, Pajewski NM, Bates JT, et al. Effect of Intensive Versus Standard Clinic-Based Hypertension Management on Ambulatory Blood Pressure: Results From the SPRINT Ambulatory Blood Pressure Study. Hypertension. 2017;69(1):42–50.PubMed
59.
Zurück zum Zitat Victor RG, Lynch K, Li N, et al. A Cluster-Randomized Trial of Blood-Pressure Reduction in Black Barbershops. N Engl J Med. 2018;378(14)1291–1301.PubMedPubMedCentral Victor RG, Lynch K, Li N, et al. A Cluster-Randomized Trial of Blood-Pressure Reduction in Black Barbershops. N Engl J Med. 2018;378(14)1291–1301.PubMedPubMedCentral
Metadaten
Titel
Impact of a Patient-Centered Behavioral Economics Intervention on Hypertension Control in a Highly Disadvantaged Population: a Randomized Trial
verfasst von
Martin F. Shapiro, MD, CM, PhD
Suzanne B. Shu, PhD
Noah J. Goldstein, PhD
Ronald G. Victor, MD
Craig R. Fox, PhD
Chi-Hong Tseng, PhD
Sitaram Vangala, MA
Braden K. Mogler, MD
Stewart B. Reed, MD
Estivali Villa, BA
José J. Escarce, MD, PhD
Publikationsdatum
12.09.2019
Verlag
Springer US
Erschienen in
Journal of General Internal Medicine / Ausgabe 1/2020
Print ISSN: 0884-8734
Elektronische ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-019-05269-z

Weitere Artikel der Ausgabe 1/2020

Journal of General Internal Medicine 1/2020 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.